LOADING
USCCB releases statement on chemical abortion pill
December 30, 2021
WASHINGTON — The U.S. Food and Drug Administration announced they will eliminate the safety requirement of in-person dispensing in the Risk Evaluation Mitigation Strategy for the chemical abortion drug mifepristone. The FDA’s action clears a ...
chat_bubble0 Comment
visibility475 Views
